Patient Education for Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if educating patients can improve adherence to heart failure treatment plans. The focus is on heart failure with reduced ejection fraction, where the heart doesn't pump as effectively as it should. Participants will attend educational sessions about their treatment's benefits and side effects at various intervals after hospital discharge. The trial seeks individuals hospitalized for heart failure with an ejection fraction of 40% or less. As an unphased trial, it offers a unique opportunity for patients to contribute to valuable research that could enhance treatment adherence and outcomes for heart failure patients.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It focuses on patient education for heart failure treatment adherence.
What prior data suggests that this patient education protocol is safe?
Research has shown that educating people about heart failure is a safe and effective way to support them. Studies have found that when patients understand their treatment, they manage their condition better. This includes taking medication correctly, making healthy lifestyle changes, and monitoring symptoms.
Patient education does not involve new drugs or medical procedures, so it avoids safety concerns like medication side effects. Instead, it provides information and support, building confidence and encouraging healthier habits.
In summary, patient education is safe and well-received. It helps people manage their heart health better without direct risks.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it focuses on enhancing patient education for heart failure management. Unlike standard treatments that primarily focus on medication, this approach emphasizes comprehensive education on guideline-directed medical therapy (GDMT), aiming to improve patient adherence and understanding. The intervention includes personalized education during hospital stays and follow-up sessions over the phone, providing ongoing support and addressing barriers to medication adherence. This proactive and educational approach could lead to better long-term outcomes for patients by empowering them to manage their condition more effectively.
What evidence suggests that patient education is effective for improving adherence to GDMT in heart failure with reduced ejection fraction?
Research has shown that educating patients about their condition can significantly aid those with heart failure. In this trial, participants in the intervention arm will receive comprehensive education, including face-to-face sessions and follow-up phone education. Studies have shown that this approach leads to fewer hospital visits and emergencies. Specifically, one study demonstrated that learning about their condition improved both the physical and mental health of patients. Those who received education experienced better treatment outcomes and fewer issues with their heart's ability to pump blood. Additionally, educating patients reduced death rates and increased their understanding of heart failure, enabling them to manage their care more effectively. Overall, patient education has proven highly beneficial for managing heart failure.56789
Who Is on the Research Team?
Anup Agarwal, MD
Principal Investigator
MedStar Health
Are You a Good Fit for This Trial?
This trial is for patients with heart failure where the heart's pumping power is reduced. They should be recently discharged from the hospital and willing to learn about their treatment guidelines at set intervals after discharge.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Education
Participants receive initial face-to-face education during hospital admission and an educational flier about GDMT
Post-Discharge Education
Intervention group receives additional education via phone at 1, 3, and 5 months post-discharge, including GDMT benefits, side effects, and adherence encouragement
Follow-up
Participants are monitored for changes in GDMT score and other health outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Patient Education
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medstar Health Baltimore
Lead Sponsor